ClinicalTrials.gg
RecruitingNCT07520786DAWG-TREATUpdated Apr 9, 2026

Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women

An interventional study of Time Restricted Eating and Control in Sleep Quality, Compliance and Physical Activity, sponsored by University of Georgia. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by University of Georgia · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 26 Years
Sex
Female
01

Study summary

Time-restricted Eating (TRE) is a dietary approach that limits food intake to 4 - 12-hour windows without intentionally altering diet quality. TRE has several benefits including modest reductions in body weight and fat mass, improved glucose control, and reduced inflammatory markers. While research supports the metabolic and weight related benefits of TRE, there is limited evidence of its effects on physical activity (PA), sedentary behavior (SB) and sleep - the core components of 24-hour Activity Cycle (24-HAC), which is a holistic framework that integrates the three health-related activities. TRE research has largely focused on clinical populations, leaving its feasibility and adherence in healthy younger adults understudied. Within this group, college students' misaligned circadian rhythms and unpredictable schedules may make adherence to TRE challenging, highlighting the need for research on its practicality in this group. These outcomes are also particularly important to investigate in women, considering that SB is more prevalent among college-aged women (69%) compared to men (46%). To address these issues, we will conduct a three-week intervention to study the effects of TRE on the 24-HAC outcomes. College aged women will be screened and enrolled, then assigned to either a control or TRE group. Participants in the TRE group will self-select the timing of their 8-hour eating window which they will maintain throughout the study (with compliance on at least six days per week needed to be considered adherent). The control group will receive a basic nutrition education at the start of the study and will have no restriction on eating times. 24 HAC behaviors will be measured continuously for one-week of baseline measurement and throughout the intervention by wrist-worn ActiGraph GT9X monitors. Participants will also record the timing of their first and last meal each day and receive periodic reminders to report their hunger and satiety ratings using visual analog scales.

02

Conditions studied

  • Sleep Quality
  • Compliance
  • Physical Activity
  • Sedentary Behaviors
  • Sleep Duration

Keywords

  • Time restricted eating
  • Sleep quality
  • 24-Hour activity cycle
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 36 is below the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

University of Georgia is the lead sponsor of 74 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female undergraduate and graduate students
  • Enrolled full-time at University of Georgia
  • Aged 18-26 years

Exclusion criteria

Exclusion Criteria:

  • having one of the following chronic diseases that maybe impacted by the diet changes: type 1 and 2 diabetes mellitus, cancer, cardiovascular diseases, hypertension, thyroid dysfunction, hepatic/renal impairment, inflammatory bowel disease and other gastrointestinal diseases,
  • report use of nicotine, thyroid medications, antidepressants, or anti-anxiety medications, melatonin
  • having clinically diagnosed sleep disorders
  • alcohol intake exceeds two drinks per day
  • clinically diagnosed or undiagnosed eating disorders
  • division-1 student athletes
  • pregnant or lactating or plan on getting pregnant within 6 months
  • report major ambulatory disorders,
  • recently (within the past two weeks) engaged in caloric restriction, timing-based dietary changes, weight loss regimens, or adhered to specialized diets such as ketogenic or paleo diets,
  • required to take medication with food, as these factors may interfere with sleep and physical activity outcomes or pose risks to participant health during restricted eating protocols. Students whose habitual eating time windows are \<10 hours will also not be eligible.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Time Restricted Eating (TRE)

    8-hour (self-selcted) TRE

    Behavioral: Time Restricted Eating

  • Other
    Control

    Normal eating

    Behavioral: Control

Interventions

  • BehavioralTime Restricted Eating

    Participants randomized to the TRE group will self-select a consistent 8-hour daily eating window that aligns with their usual schedule. Participants will be instructed to consume all caloric intake within this 8-hour window and abstain from caloric intake outside of the window for 3 weeks. Participants will be instructed not to intentionally modify diet quality or caloric intake during the intervention period, aside from restricting meal timing. Consumption of water and non-caloric beverages (e.g., black coffee, unsweetened tea) will be permitted outside the eating window to maintain hydration.

    Also known as: TRE

  • BehavioralControl

    The control group in this study will receive a basic nutrition education. This group will follow normal eating patterns for 3 weeks.

06

What researchers measure

Primary outcomes

  1. 24-Hour Activity Cycle

    Physical activity (PA), sedentary behavior (SB) and sleep duration, the three main components of 24-Hour Activity Cycle will be measured using an ActiGraph GT9X (wrist watch style activity monitor) worn continuously on the non-dominant wrist during baseline and intervention weeks. ActiGraph accelerometers are widely used for measuring PA intensity and SB time, energy expenditure and sleep. Non-sedentary time will be used as a metric to measure time spent in PA. The Choi 90-minute algorithm will be used to identify ActiGraph non-wear times. Participants will report their sleep time and wake time in the Daily Survey. Total sleep time will be calculated as the difference in their self-reported sleep and wake times.

    Time frame: From enrollment to the end of study participation (4 weeks)

Secondary outcomes

  1. Sleep quality: Objective

    ActiGraph sleep measures will be used to objectively estimate sleep quality. ActiGraphy has been previously used in TRE studies to track sleep quality. Sleep quality parameters from the ActiGraph include sleep latency, sleep efficiency and wake after sleep onset (WASO).

    Time frame: From enrollment to the end of study participation (4 weeks)

  2. Sleep quality: Subjective

    For a subjective measure of sleep quality, Pittsburgh Sleep Quality Index (PSQI) will be used. PSQI is a self-report questionnaire that assesses multiple dimensions of sleep, including both subjective and objective parameters. PSQI has a total global score ranging from 0 to 21. A score of 0 indicates the best sleep quality, while 21 indicates the worst. A total score greater than 5 is generally considered to indicate poor sleep quality. It is a well validated and reliable measure of sleep quality over a one-month interval.

    Time frame: At the beginnning of the study and at the end of study

Other outcomes

  1. Hunger and Fullness

    A Hunger and Fullness visual analogue scale will be used to assess hunger and appetite. Participants will self-administer this scale three times (wake time, midday, and bedtime) on a randomly chosen day each week.

    Time frame: Three times on one randomly day for 4 weeks

  2. Mood states

    Mood states will be assessed using Positive and Negative Affect Schedule-Short Form (PANAS-SF), which will be administered three times (wake-time, midday, and sleep time) on a randomly selected day once a week. Scores for both Positive Affect (PA) and Negative Affect (NA) range from 10 to 50, with higher scores indicating higher levels of that emotional state

    Time frame: Once a week for 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Physical Activity Measurement Lab
    Athens, Georgia 30605, United States
    Recruiting
    • Tejaswi Tamilmani Saraswathi, MS · Contacttt34515@uga.edu · 9515362830
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07520786
Lead sponsor
University of Georgia
Responsible party
Michael Schmidt (Professor, University of Georgia) — Principal investigator
First posted
Apr 9, 2026
Start date
Feb 1, 2026
Primary completion
Nov 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Apr 9, 2026

Study contacts

Tejaswi Tamilmani Saraswathi, MS
Contact
tt34515@uga.edu
19515362830
Michael D Schmidt, Ph.D.
principal investigator · University of Georgia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion